|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 1625 I Street NW |
Address2 | Suite 550 |
| City | WASHINGTON |
State | DC |
Zip Code | 20006 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 8497-12
|
||||||||
|
6. House ID# 320220000
|
||||||||
| TYPE OF REPORT | 8. Year | 2026 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Catherine Hurley |
Date | 10/15/2026 12:07:41 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
(S.335) - The Rural Hospital Support Act - Expressed support for the Rural Hospital Support Act. This legislation would provide assistance to rural hospitals through the Medicare program, including making the Medicare-dependent Hospital Program permanent.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, President of the U.S., Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paulo |
Pontemayor |
|
|
|
Lucas |
Swanepoel |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
(H.R. 529) - The Protecting Sensitive Locations Act - Expressed support for the Protecting Sensitive Locations Act. This legislation would codify the previous and longstanding guidance into law, prohibiting immigration enforcement actions by officers or agents at or within 1,000 feet of healthcare facilities such as hospitals, community health centers, and accredited health clinics. The protections in the bill also would extend to educational and social service facilities as well as places of worship, among others.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kathy |
Curran |
|
|
|
Jenn |
Maez |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Urged Congress to increase funding for the Childrens Hospitals Graduate Medical Education (CHGME) program to $1.02 billion in FY 2027 to help address the growing pediatric workforce shortage. CHGME plays a critical role in training more than half of the nations pediatricians and specialists, ensuring children across the country have access to timely, high-quality care. Strengthening this program is essential to sustaining and expanding the pediatric care pipeline now and into the future.
Urged Congress to increase FY 2027 funding for federal firearm injury prevention research, requesting $35 million for the CDC, $25 million for the NIH, and $1 million for the National Institute of Justice. This funding is critical to advancing evidence-based solutions to reduce firearm-related injuries, deaths, and suicides, and to strengthen public health and community safety nationwide.
Expressed support for several provisions of the appropriations bill that extend expiring health programs and allocate funding for the Department of Labor, Health and Human Services, Education, and Related Agencies (Labor-HHS-ED).
Urged Congress to find a solution that extends the Marketplace enhanced premium tax credits (EPTCs).
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paulo |
Pontemayor |
|
|
|
Lucas |
Swanepoel |
|
|
|
Joe |
Lepore |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
(H.R. 9504)- Tax Exempt Hospital Transparency Act- Expressed that Congress should first review existing oversight findings and determine whether additional requirements are necessary, targeted, and workable.
(S. 3702/H.R. 7165) The Credit for Caring Act - Expressed support for the Credit Caring Act. The legislation would create a new, non-refundable federal tax credit for eligible working family caregivers to help address the financial challenges of caregiving.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paulo |
Pontemayor |
|
|
|
Lucas |
Swanepoel |
|
|
|
Nancy |
Lim |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Expressed support for Section 340B of the Public Health Service Act. Urged Congress to revise Section 2 in line with concerns expressed over discussion draft on rebate conditions; that the current HRSA standard of additional definitions in Section 4 remain in place; that Section 8 recognize that child sites operated through other appropriate affiliated structures, in addition to wholly owned facilities, align compliance requirements with existing Medicare provider-based standards, and reconsider the proposed charity-care and Medicaid/CHIP revenue benchmarks to account for state and community variation.
(H.R. 9393) - The Lower Costs, More Transparency Act of 2026 and (H.R. 9390) - The Prices on the Wall Act of 2026 - Urged Congress to ensure that any new transparency requirements are aligned with existing federal rules, avoid duplication, recognize the complexity of health care pricing, and provide sufficient flexibility for hospitals serving diverse communities and patient populations.
(H.R. 9645) - The Health Care Price Certainty for All Americans Act - Urged Congress to ensure that any new transparency requirements are aligned with existing federal rules, avoid duplication, recognize the complexity of health care pricing, and provide sufficient flexibility for hospitals serving diverse communities and patient populations.
(S.2372/H.R.4581) - 340B PATIENTS Act of 2025-Expressed support for the 340B Patients Act. This legislation would codify 340B providers' ability to use contract pharmacies to dispense 340B discounted drugs, ensure that 340B patients can pick up their prescriptions at any local pharmacy, and allow safety-net providers to continue providing expanded medical and social services to their communities using their 340B discount savings.
(S. 2287/H.R. 4425) - Palliative Care and Hospice Education and Training Act (PCHETA) - Expressed support for the Palliative Care and Hospice Education and Training Act (PCHETA). This legislation would increase the number of permanent faculty in palliative care in medical schools, nursing schools, and other programs, promote education and research in palliative care and hospice, and support the development of faculty careers in academic palliative and hospice
(S. 380) - Rural Obstetrics Readiness Act - Expressed support for the Rural Obstetrics Readiness Act. This bipartisan legislation would ensure that rural health care facilities are equipped with targeted resources to provide high-quality obstetric care to women within their own communities.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), President of the U.S., Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paulo |
Pontemayor |
|
|
|
Lucas |
Swanepoel |
|
|
|
Leila |
Nimatallah |
|
|
|
Joe |
Lepore |
|
|
|
Jenn |
Maez |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CIV
16. Specific lobbying issues
(H.R. 1144) - Frederick Douglass Trafficking Victims Prevention Protection and Reauthorization Act of 2025. Urged the House to advance this bill, which would bolster the nations efforts to eradicate human trafficking and assist human trafficking survivors.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lucas |
Swanepoel |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |